<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To evaluate association between DNA methylation of MAL, CDKN2A, and MGMT in stool and development of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, and to evaluate the screening value of these biomarkers in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> and <z:e sem="disease" ids="C0850639" disease_type="Neoplastic Process" abbrv="">pre-malignant lesions</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Morning stool specimens were collected from 69 patients with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, 24 with colon <z:mpath ids='MPATH_270'>adenoma</z:mpath>, 19 with <z:mpath ids='MPATH_140'>hyperplastic polyps</z:mpath>, and 26 healthy controls </plain></SENT>
<SENT sid="2" pm="."><plain>DNA was extracted and treated with <z:chebi fb="0" ids="17137">bisulfite</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>Methylation-specific PCR(MSP) was performed for methylation analysis of MAL, CDKN2A and MGMT in DNA samples </plain></SENT>
<SENT sid="4" pm="."><plain>Associations between clinicopathological features and gene methylation were analyzed </plain></SENT>
<SENT sid="5" pm="."><plain>The sensitivity of diagnosis by combining three methylation markers was compared with fecal occult blood test(FOBT) </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: The methylation frequencies of MAL, CDKN2A and MGMT were 78.3%, 52.5% and 55.1% in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, 58.3%, 41.7% and 37.5% in colon <z:mpath ids='MPATH_270'>adenomas</z:mpath>, 26.3%, 15.8% and 10.5% in <z:mpath ids='MPATH_140'>hyperplastic polyps</z:mpath>, and 3.8%, 0 and 3.8% in healthy controls, respectively </plain></SENT>
<SENT sid="7" pm="."><plain>Significant differences in three genes were found between <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> and <z:mpath ids='MPATH_140'>hyperplastic polyp</z:mpath>, <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> and healthy control, colon <z:mpath ids='MPATH_270'>adenoma</z:mpath> and <z:mpath ids='MPATH_140'>hyperplastic polyp</z:mpath>, colon <z:mpath ids='MPATH_270'>adenoma</z:mpath> and healthy control(<z:hpo ids='HP_0000001'>all</z:hpo> P&lt;0.05) </plain></SENT>
<SENT sid="8" pm="."><plain>The diagnostic sensitivity by combining three methylation markers was 92.8% in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, 70.8% in colon <z:mpath ids='MPATH_270'>adenomas</z:mpath>, significantly higher than FOBT examination (29.0% in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> and 25.0% in colon <z:mpath ids='MPATH_270'>adenomas</z:mpath>, <z:hpo ids='HP_0000001'>all</z:hpo> P&lt;0.05) </plain></SENT>
<SENT sid="9" pm="."><plain>No significant associations existed between three genes methylation of the three genes and clinical characteristic including sex, age, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> location, <z:e sem="disease" ids="C0686619" disease_type="Neoplastic Process" abbrv="">lymph node metastases</z:e> and TNM stage (<z:hpo ids='HP_0000001'>all</z:hpo> P&gt;0.05) </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSION: DNA methylations levels of MAL, CDKN2A, and MGMT in stools are significantly higher in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> and colon <z:mpath ids='MPATH_270'>adenoma</z:mpath>, which may serve as an noninvasive approach for the screening of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> and <z:e sem="disease" ids="C0850639" disease_type="Neoplastic Process" abbrv="">pre-malignant lesions</z:e> </plain></SENT>
</text></document>